Normal view

Received — 12 January 2026 ⏭ Favourites

FDA Press Releases RSS Feed
FDA Increases Flexibility on Requirements for Cell and Gene Therapies to Advance Innovation FDA
The U.S. Food and Drug Administration today announced it is sharing information about the agency’s flexible approach to overseeing chemistry, manufacturing and control (CMC) requirements for cell and gene therapies (CGT).
12 January 2026 at 04:03

FDA Increases Flexibility on Requirements for Cell and Gene Therapies to Advance Innovation

12 January 2026 at 04:03

The U.S. Food and Drug Administration today announced it is sharing information about the agency’s flexible approach to overseeing chemistry, manufacturing and control (CMC) requirements for cell and gene therapies (CGT).